AHFS Drug Information (2018) by pharmacists for ..
APK 다운로드AHFS Drug Information (2018) by pharmacists for .. 앱 스크린샷
AHFS Drug Information (2018) by pharmacists for .. AI 편집자의 리뷰
AHFS Drug Information (2018) provides comprehensive, evidence-based drug information for healthcare professionals. It offers reliable data, but the 2018 version may lack the latest updates. Free trial available.
종합 분석
AHFS Drug Information (2018) is a valuable resource for pharmacists and other healthcare providers seeking detailed drug information. The app offers monographs covering indications, dosage, adverse effects, and interactions. While the information is comprehensive and evidence-based, the 2018 edition may not reflect the most recent drug approvals or guideline updates. The 'try before you buy' option is a definite plus, allowing users to assess its suitability before committing to a purchase. However, the user interface could benefit from improvements to enhance navigation and search functionality.
주요 장점
- Comprehensive and evidence-based drug information.
- Written by pharmacists for healthcare professionals.
- Offers a 'try before you buy' free trial.
개선 영역
- The 2018 version may be outdated compared to current drug information.
- Navigation can be improved for faster information retrieval.
설명 AHFS Drug Information (2018) by pharmacists for ..
Site Editorial Commentary：Drug guide published by the American Society of Health-System Pharmacists
Experience the "Try before you buy" feature by downloading the FREE AHFS Drug Information (2018) App, which provides sample content. Unlock the full potential of this comprehensive drug information resource with an in-app purchase.AHFS® Drug Information™ is a Doody's Core Title, offering a complete, interactive solution for drug therapy and treatment. It includes therapeutic guidelines and off-label uses, making it an essential tool for healthcare professionals.
This app is a Doody's Core Title selection for 2020, 2021, 2022, 2023, and 2024.
AHFS Drug Information® 2025 provides the most reliable drug information available, drawing from extensive evidence and expert advice. It is a comprehensive, evidence-based resource, complete with therapeutic guidelines and off-label uses.
With over 97,000 references and contributions from numerous subject matter experts, AHFS DI helps healthcare providers protect their patients and improve their practice.
Key updates in the new edition include:
- Clinical perspective sections with therapy discussions and recommendations.
- Expanded coverage of specialty medications for complex, chronic conditions.
- Contemporary topics such as vaccines and treatments for mPox disease, new RSV treatments and vaccines, and safety issues related to GLP-1 agonists.
- Content on new and emerging gene therapies.
- Pharmacogenomic considerations for drug dosing and selection.
- Updates to vaccine monographs, including influenza, COVID-19, pneumococcal, and RSV vaccines.
- Expanded content on off-label uses and real-world data.
- MedWatch alerts, Standardize4Safety concentration standards, REMS data, and FDA safety findings.
- New content on over 200 new molecular entities (NMEs) and revisions on approximately 265 medications.
- Oncology off-label determinations based on AHFS Oncology Expert Committee reviews.
Content is licensed from printed ISBN 10: 158528761X and ISBN 13: 9781585287611.
SUBSCRIPTION INFORMATION:
Receive access to content and updates with a yearly auto-renewing subscription.
Yearly auto-renewing payments: $99.99
Payment will be charged upon confirmation of purchase. The subscription automatically renews unless auto-renewal is disabled at least 24 hours before the end of the current period. Manage your subscription and disable auto-renewal in your App “Settings”. Any unused portion of a free trial will be forfeited upon subscription purchase.
Privacy Policy: https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions: https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Editor: American Society of Health-System Pharmacists, Inc.
Publisher: American Society of Health-System Pharmacists, Inc.
